MedTrace Logo

Neural Biomarkers in Fragile X Syndrome

NCT06957054 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-05-04

No results posted yet for this study

Summary

The purpose of this non-interventional test /re-test study is to assess neural biomarkers in adult subjects with Fragile X syndrome compared to those measured in a population of typically developing adults

Conditions

  • Fragile X Syndrome (FXS)
  • Neurotypical Adults

Interventions

OTHER

Any

Any

Sponsors & Collaborators

  • Hospital del Mar Research Institute (IMIM)

    collaborator OTHER

  • Corporacion Parc Tauli

    collaborator OTHER

  • Ministry of Science and Innovation, Spain

    collaborator OTHER_GOV

  • Connecta Therapeutics, S.L.

    lead INDUSTRY

Principal Investigators

  • Rafael De la Torre Fornell, Pharm, PhD · Hospital del Mar Research Institute

  • Ana Roche Martínez, MD, PhD · Consorci Corporació Sanitària Parc Taulí. Institut d'Investigació i Innovació Parc Taulí (I3PT)

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-16
Primary Completion
2025-03-20
Completion
2025-03-20

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06957054 on ClinicalTrials.gov